The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Common Estrogen Receptor Polymorphism Augments Effects of Hormone Replacement Therapy on E-Selectin but Not C-Reactive Protein
Open accessAbstract
Background — The estrogen receptor-α (ER-α) IVS1-401 polymorphism identifies a group of women (≈20%) who have augmented effects of hormone replacement therapy (HRT) on levels of HDL cholesterol. This study sought to determine if this augmentation extends to HRT regulation of E-selectin and C-reactive protein (CRP) and to explore possible mechanisms by which this polymorphism might influence estrogen action. Methods and Results — Serum levels of soluble E-selectin and CRP were measured at baseline and 1 year in 264 postmenopausal women randomized to treatment with oral conjugated equine estrogen (0.625 mg/d), estrogen plus progestin (medroxyprogesterone acetate 2.5 mg/d), or placebo. Women with the ER-α IVS1-401 C/C genotype receiving HRT had nearly a 2-fold greater reduction in E-selectin compared with C/T or T/T women ( P for interaction=0.02). In contrast, there was no augmentation of the HRT-associated increase in CRP among the C/C women compared with C/T or T/T women ( P for interaction=0.54). Of luciferase reporter constructs containing sequences spanning the IVS1-401 T/C polymorphism, expression of the construct containing the C allele was enhanced >10-fold, with cotransfection of a constitutively expressed B-myb vector. In contrast, B-myb resulted in only a 2.5-fold increase in expression of the T allele construct. Conclusions — Women with the ER-α IVS1-401 C/C genotype have greater reductions in E-selectin but no further increases in CRP with HRT. The C allele produces a functional binding site for the transcription factor B-myb. The impact of this polymorphism on ER-α transcription and other estrogen-sensitive intermediate and clinical end points has not yet been established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Self-citationA Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C.-R., Liu, C.-H., Azen, S. P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 687
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein
Ridker, P. M., Hennekens, C. H., Rifai, N., Buring, J. E., & Manson, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.7.713 · Cited by 443
Herrington, D. M., Howard, T. D., Hawkins, G. A., Reboussin, D. M., Xu, J., Zheng, S. L., Brosnihan, K. B., Meyers, D. A., & Bleecker, E. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012952 · Cited by 374
Self-citationAngerer, P., Störk, S., Kothny, W., Schmitt, P., & von Schacky, C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.2.262 · Cited by 240
Hormone Replacement Therapy, Inflammation, and Hemostasis in Elderly Women
Cushman, M., Meilahn, E. N., Psaty, B. M., Kuller, L. H., Dobs, A. S., & Tracy, R. P. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.893 · Cited by 218
Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells1
Jeng, M.-H., Shupnik, M. A., Bender, T. P., Westin, E. H., Bandyopadhyay, D., Kumar, R., Masamura, S., & Santen, R. J. (1998) · Endocrinology · doi:10.1210/endo.139.10.6229 · Cited by 175
Cited by
Ralston, S. H., & Uitterlinden, A. G. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0044 · Cited by 376
Genetic regulation of bone mass and susceptibility to osteoporosis
Ralston, S. H., & de Crombrugghe, B. (2006) · Genes & Development · doi:10.1101/gad.1449506 · Cited by 364
Ioannidis, J. P. A. (2004) · JAMA · doi:10.1001/jama.292.17.2105 · Cited by 297
Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity
Turgeon, J. L., McDonnell, D. P., Martin, K. A., & Wise, P. M. (2004) · Science · doi:10.1126/science.1096725 · Cited by 297
Self-citationAssociation Between Estrogen Receptor α Gene Variation and Cardiovascular Disease
Shearman, A. M., Cupples, L. A., Demissie, S., Peter, I., Schmid, C. H., Karas, R. H., Mendelsohn, M. E., Housman, D. E., & Levy, D. (2003) · JAMA · doi:10.1001/jama.290.17.2263 · Cited by 277
Metadata
- Authors
- Herrington, D. M., Howard, T. D., Brosnihan, K. B., McDonnell, D. P., Li, X., Hawkins, G. A., Reboussin, D. M., Xu, J., Zheng, S. L., Meyers, D. A., & Bleecker, E. R.
- Venue
- Circulation
- Published
- 2002-04-23
- Volume
- 105
- Issue
- 16
- Pages
- 1879-1882
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2164374136
- Cited by
- 338
- References
- 13
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Common Estrogen Receptor Polymorphism Augments Effects of Hormone Replacement Therapy on E-Selectin but Not C-Reactive Protein. https://app.cochat.ai/papers/10.1161/01.cir.0000016173.98826.88
- The paper
- Herrington, D. M., Howard, T. D., Brosnihan, K. B., McDonnell, D. P., Li, X., Hawkins, G. A., Reboussin, D. M., Xu, J., Zheng, S. L., Meyers, D. A., & Bleecker, E. R. (2002). Common Estrogen Receptor Polymorphism Augments Effects of Hormone Replacement Therapy on E-Selectin but Not C-Reactive Protein. Circulation. https://doi.org/10.1161/01.cir.0000016173.98826.88
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.